Pharmacologic inhibition of ataxia telangiectasia and Rad3‐related (ATR) in the treatment of head and neck squamous cell carcinoma
Author:
Affiliation:
1. Department of Radiation Oncology Duke University Medical Center Durham North Carolina USA
2. Department of Head and Neck Surgery & Communication Sciences Duke University Medical Center Durham North Carolina USA
Funder
Damon Runyon Cancer Research Foundation
National Institute of Dental and Craniofacial Research
Publisher
Wiley
Subject
Cancer Research,Molecular Biology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23384
Reference188 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2. The molecular biology of head and neck cancer
3. Head and Neck Cancer
4. ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
5. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent anti-PD-L1- and anti-NKG2A-based adjuvant immunotherapy;2023-11-12
2. The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines;Investigational New Drugs;2023-11-07
3. The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors;Pathology - Research and Practice;2023-11
4. Novel insights into DNA damage repair defects in HPV-positive head and neck squamous cell carcinoma: from the molecular basis to therapeutic opportunities;Genome Instability & Disease;2023-10-11
5. Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation;International Journal of Molecular Sciences;2023-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3